Cardiometabolic Considerations: The Role of LDL-C in ASCVD Risk Assessment & Insights into Optimal Management

Guest: Norman E. Lepor, MD <br> <p>Tune in to hear Dr. Norman Lepor from the UCLA Geffen School of Medicine discuss the role of LDL-C and comorbidities in atherosclerotic cardiovascular disease (ASCVD) risk assessment as well as the limitations of statin treatment.</p> <p style="text-align: right;"><span>10</span>/21 121913</p> <div> </div> <p style="text-align: right;"><span><span> </span></span></p>